申请人:ZENYAKU KOGYO KABUSHIKI KAISHA
公开号:EP0138058A1
公开(公告)日:1985-04-24
Disclosed is a novel 1,4-thiazine derivative represented by the following general formula I and a pharmaceutically acceptable acid addition salt thereof:
wherein R1, R2 and R3 respectively represent a hydrogen atom or a lower alkyl group. Also disclosed are processes for preparation of a novel thiazine derivative represented by the general formula I, which comprise reacting a compound of the general formula III with a compound of the general formula A-X' in a compound containing a pyridinyl group as a solvent to obtain a compound of the general formula II:
wherein R,, R2 and R3 are as defined above, A represents a group
in which X represents a halogen atom and n is a number of 1 to 3, and X' represents a halogen atom which may be the same as or different from X, and reacting the compound of the general formula II with sulfur at elevated temperature or stirring the compound of the general formula II in a solution system comprising zinc and a carboxylic acid. Further disclosed is a cardiotonic agent comprising a pharmaceutically acceptable excipient and, as the active component thereof, an effective amount of the novel 1,4-thiazine derivative having the general formula I.
本发明公开了由以下通式 I 代表的新型 1,4-噻嗪衍生物及其药学上可接受的酸加成盐:
其中 R1、R2 和 R3 分别代表氢原子或低级烷基。还公开了制备通式 I 所代表的新型噻嗪衍生物的工艺,该工艺包括在含有吡啶基的化合物中作为溶剂使通式 III 的化合物与通式 A-X' 的化合物反应,得到通式 II 的化合物:
其中 R、R2 和 R3 如上定义,A 代表一个基团
其中 X 代表卤原子,n 为 1 至 3 的数字,X'代表卤原子,可以与 X 相同或不同,将通式 II 的化合物与硫在高温下反应,或将通式 II 的化合物在由锌和羧酸组成的溶液体系中搅拌。进一步公开的是一种强心剂,包括一种药学上可接受的赋形剂,以及作为其活性成分的有效量的具有通式 I 的新型 1,4-噻嗪衍生物。